Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10362/174791Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Seixas, Elsa | - |
| dc.contributor.author | Barros, Mafalda | - |
| dc.contributor.author | C Seabra, Miguel | - |
| dc.contributor.author | C. Barral, Duarte | - |
| dc.date.accessioned | 2024-11-07T22:23:27Z | - |
| dc.date.available | 2024-11-07T22:23:27Z | - |
| dc.date.issued | 2013-04 | - |
| dc.identifier.issn | 1398-9219 | - |
| dc.identifier.other | PURE: 293655 | - |
| dc.identifier.other | PURE UUID: abd55b8d-5ac7-4e9f-a4a9-cf2c5b3d4b7b | - |
| dc.identifier.other | researchoutputwizard: 39885 | - |
| dc.identifier.other | PubMed: 23565987 | - |
| dc.identifier.other | WOS: 000321434400001 | - |
| dc.identifier.other | Scopus: 84880131899 | - |
| dc.identifier.other | ORCID: /0000-0001-8867-2407/work/123561622 | - |
| dc.identifier.uri | http://hdl.handle.net/10362/174791 | - |
| dc.description.abstract | Rab and ADP-ribosylation factor (Arf) family proteins are master regulators of membrane trafficking and are involved in all steps of vesicular transport. These families of small guanine-nucleotide-binding (G) proteins are well suited to regulate membrane trafficking processes since their nucleotide state determines their conformation and the capacity to bind to a multitude of effectors, which mediate their functions. In recent years, several inherited diseases have been associated with mutations in genes encoding proteins belonging to these two families or in proteins that regulate their GTP-binding cycle. The genetic diseases that are caused by defects in Rabs, Arfs or their regulatory proteins are heterogeneous and display diverse symptoms. However, these diseases mainly affect two types of subcellular compartments, namely lysosome-related organelles and cilia. Also, several of these diseases affect the nervous system. Thus, the study of these diseases represents an opportunity to understand their etiology and the molecular mechanisms involved, as well as to develop novel therapeutic strategies. | en |
| dc.language.iso | eng | - |
| dc.rights | openAccess | - |
| dc.subject | AMPA RECEPTORS | - |
| dc.subject | secretion | - |
| dc.subject | CHYLOMICRON RETENTION DISEASE | - |
| dc.subject | ciliopathies | - |
| dc.subject | GRISCELLI-SYNDROME | - |
| dc.subject | lysosome-related organelles | - |
| dc.subject | small GTPases | - |
| dc.subject | membrane trafficking | - |
| dc.subject | RETINAL-PIGMENT EPITHELIUM | - |
| dc.subject | BARDET-BIEDL-SYNDROME | - |
| dc.subject | HERMANSKY-PUDLAK-SYNDROME | - |
| dc.subject | WARBURG MICRO SYNDROME | - |
| dc.subject | GTPASE-ACTIVATING PROTEIN | - |
| dc.subject | LINKED MENTAL-RETARDATION | - |
| dc.subject | NUCLEOTIDE EXCHANGE FACTOR | - |
| dc.subject | ciliopathies | - |
| dc.subject | lysosome-related organelles | - |
| dc.subject | membrane trafficking | - |
| dc.subject | secretion | - |
| dc.subject | small GTPases | - |
| dc.title | Rab and Arf Proteins in Genetic Diseases | - |
| dc.type | article | - |
| degois.publication.firstPage | 871 | - |
| degois.publication.issue | 8 | - |
| degois.publication.lastPage | 885 | - |
| degois.publication.title | Traffic | - |
| degois.publication.volume | 14 | - |
| dc.peerreviewed | yes | - |
| dc.identifier.doi | https://doi.org/10.1111/tra.12072 | - |
| dc.description.version | publishersversion | - |
| dc.description.version | published | - |
| dc.contributor.institution | NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) | - |
| dc.contributor.institution | Centro de Estudos de Doenças Crónicas (CEDOC) | - |
| Aparece nas colecções: | NMS - Artigos em revista internacional com arbitragem científica | |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| Traffic_-_2013_-_Seixas_-_Rab_and_Arf_Proteins_in_Genetic_Diseases.pdf | 16,46 MB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.











